Bromelain and Cardiovascular Risk Factors in Diabetes

NACompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Cardiovascular Disease.
Interventions
DIETARY_SUPPLEMENT

bromelain capsule

Bromelain group received bromelain capsule for 12 weeks period. The 1050 mg dosage of bromelain was divided into three capsules and to be taken two (2 x 350 mg) after breakfast and another one (350 mg) after dinner. The capsules should be taken two hours after the meals.

DIETARY_SUPPLEMENT

placebo (wheat starch)

Placebo group received placebo capsule (wheat starch) for 12 weeks period. The 1050 mg dosage of wheat starch was divided into three capsules and to be taken two (2 x 350 mg) after breakfast and another one (350 mg) after dinner. The capsules should be taken two hours after the meals.

Trial Locations (1)

050091

Hebei Yiling Hospital, Shijiazhuang

All Listed Sponsors
collaborator

London South Bank University

OTHER

lead

Hebei Yiling Hospital

OTHER

NCT01524159 - Bromelain and Cardiovascular Risk Factors in Diabetes | Biotech Hunter | Biotech Hunter